Back

Hypokalaemia during decongestion with hydrochlorothiazide: the CLOROTIC Trial

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Management of acute heart failure: therapeutic approaches and prognosis Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Prado Salamanca Bautista

University Hospital of Virgen Macarena, Seville (Spain)

6 More presentations in this session

Presentation thumbnail
Sex-based differences in heart failure management and outcomes: insights from a national cohort of over 600,000 patients
Doctor G. Baudry (Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Loop diuretic use before an acute heart failure hospitalization drives natriuretic response but not the efficacy of natriuresis-guided diuretic therapy, a prespecified analysis from the PUSH-AHF trial
Ms L. Zonneveld (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Serum chloride and the response to combining loop and thiazide diuretics for acute heart failure: the ALCALOTIC study
Doctor R. de la Espriella (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Urinary sodium as a predictor of loop diuretic therapy post-hospitalization
Doctor F. Croset (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
The clinical outcome comparison of early versus conventional left atrial venting for left ventricular unloading in extracorporeal cardiopulmonary resuscitation patients
Professor M. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Management of acute heart failure: therapeutic approaches and prognosis
Video

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Serum chloride and the response to combining loop and thiazide diuretics for acute heart failure: the ALCALOTIC study
thumbnail
Congress Presentation
Hypokalemia during hospitalization: a strong predictor of mortality in acute heart failure
thumbnail
Congress Presentation
Hyperkalemia prevalence in ambulatory patients with chronic heart failure and reduced ejection fraction in a third level center

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources